| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |